New deals in the German drug packaging sector

By Gareth Macdonald

- Last updated on GMT

Related tags Germany

Expansion has been a theme for German pharmaceutical packaging firms of late with the acquisition of Seidenader Maschinenbau by the Kober Group following just weeks after Edelmann bought a stake in Hungary’s Zalai Nyomda

Technology firm Kober Group announced its acquisition of fellow Germany-based Seidenader Maschinenbau earlier this week, explaining that the move was designed to expand its pharmaceutical packaging systems business.

Seidenader spokeswoman Simone Steiner told in-Pharmatechnologist the firm “is a good fit for Körber Medipak. It’s enlarging our portfolio in the area of Vision systems, Track & Trace and Inspection systems​.”

She added that no operational changes will occur at Seidenader, which employs 365 people at sites in Germany and the US and generates sales of €55m a year, and predicted that ownership by Korner would provide the firm with a strong platform for growth.

In a press statement Kober CEO Richard Bauer was equally positive about the deal, describing Seidenader as an “innovative company with very interesting technologies with which we will be able to expand out activities in the healthcare market​.”

Seidenader will operate as part of the groups’ Korber Medipak pharmaceutical packaging technology unit, which generated sales of €132 million in the 2009 financial year.

Edelmann buys stake in Zalai

German pharmaceutical packaging group Edelmann also has its eye set on expansion, as evidenced by its acquisition of a majority stake in Hungarian printing firm Zalai Nyomda last month.

According to Edelmann Zalai is one of the largest producers of folding cartons and labels in the Eastern European and Middles Easter markets that offers significant potential for growth and “widens [the firm’s] spectrum for packaging solutions.”

With the Hungarian takeover Edelmann is now able to expand its portfolio for international customers in the healthcare and beauty business based in Eastern Europe​.”

Edelmann, which operates 12 facilities in Germany, Poland and China and employs 1,500 people, currently generates some 40 per cent of its €190m a year turnover in international markets.

Related news

Show more

Related products

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Follow us

Products

View more

Webinars